相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。ALDH1 expression is correlated with pathologic grade and poor clinical outcome in patients with astrocytoma
Ding-yang Liu et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2012)
Correlation of low SLC22A18 expression with poor prognosis in patients with glioma
Sheng-Hua Chu et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2012)
Prolonged temozolomide for treatment of glioblastoma: preliminary clinical results and prognostic value of p53 overexpression
Nadia Malkoun et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
Glioblastoma with an oligodendroglioma component: distinct clinical behavior, genetic alterations, and outcome
Yongzhi Wang et al.
NEURO-ONCOLOGY (2012)
Girdin maintains the stemness of glioblastoma stem cells
A. Natsume et al.
ONCOGENE (2012)
Loss of PTEN Is Not Associated with Poor Survival in Newly Diagnosed Glioblastoma Patients of the Temozolomide Era
Christine Carico et al.
PLOS ONE (2012)
Expression profile of the N-myc Downstream Regulated Gene 2 (NDRG2) in human cancers with focus on breast cancer
Anders Lorentzen et al.
BMC CANCER (2011)
Expression and prognostic Value of NDRG2 in human astrocytomas
Li Li et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2011)
Promoter methylation and downregulation of SLC22A18 are associated with the development and progression of human glioma
Sheng-Hua Chu et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
Aldehyde Dehydrogenase 1 A1-Positive Cell Population Is Enriched in Tumor-Initiating Cells and Associated with Progression of Bladder Cancer
Yun Su et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Aldehyde Dehydrogenase 1-Positive Cancer Stem Cells Mediate Metastasis and Poor Clinical Outcome in Inflammatory Breast Cancer
Emmanuelle Charafe-Jauffret et al.
CLINICAL CANCER RESEARCH (2010)
SINGLE-MARKER IDENTIFICATION OF HEAD AND NECK SQUAMOUS CELL CARCINOMA CANCER STEM CELLS WITH ALDEHYDE DEHYDROGENASE
Matthew R. Clay et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2010)
High ALDH Activity Identifies Chemotherapy-Resistant Ewing's Sarcoma Stem Cells That Retain Sensitivity to EWS-FLI1 Inhibition
Ola Awad et al.
PLOS ONE (2010)
Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer
Yu-Chih Chen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Suppression of N-Myc Downstream-Regulated Gene 2 Is Associated with Induction of Myc in Colorectal Cancer and Correlates Closely with Differentiation
Hai Shi et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2009)
Aldehyde Dehydrogenase 1 Is a Marker for Normal and Malignant Human Colonic Stem Cells (SC) and Tracks SC Overpopulation during Colon Tumorigenesis
Emina H. Huang et al.
CANCER RESEARCH (2009)
Association of Breast Cancer Stem Cells Identified by Aldehyde Dehydrogenase 1 Expression with Resistance to Sequential Paclitaxel and Epirubicin-Based Chemotherapy for Breast Cancers
Tomonori Tanei et al.
CLINICAL CANCER RESEARCH (2009)
NDRG4 Is Required for Cell Cycle Progression and Survival in Glioblastoma Cells
Stephen H. Schilling et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability
Alysha K. Croker et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
Decreased expression of NDRG1 in glioma is related to tumor progression and survival of patients
Boqian Sun et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
Aldehyde Dehydrogenase 1 Is a Tumor Stem Cell-Associated Marker in Lung Cancer
Feng Jiang et al.
MOLECULAR CANCER RESEARCH (2009)
Reduced expression of N-Myc downstream-regulated gene 2 in human thyroid cancer
Huadong Zhao et al.
BMC CANCER (2008)
Frequent promoter hypermethylation and transcriptional downregulation of the NDRG2 gene at 14q11.2 in primary glioblastoma
Martin Tepel et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Prognosis of glioma patients by combined immunostaining for survivin, Ki-67 and epidermal growth factor receptor
Minoru Kogiku et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2008)
ALDH1A1 and ALDH3A1 expression in lung cancers: Correlation with histologic type and potential precursors
Miten Patel et al.
LUNG CANCER (2008)
Aldehyde Dehydrogenase as a Marker for Stem Cells
Jan S. Moreb
CURRENT STEM CELL RESEARCH & THERAPY (2008)
Expression of NDRG2 is related to tumor progression and survival of gastric cancer patients through Fas-mediated cell death
Seung-Chul Choi et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2007)
ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome
Christophe Ginestier et al.
CELL STEM CELL (2007)
Expression of NDRG2 is down-regulated in high-risk adenomas and colorectal carcinoma
Anders Lorentzen et al.
BMC CANCER (2007)
The 2007 WHO classification of tumours of the central nervous system
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2007)
Blockade of hedgehog signaling inhibits pancreatic cancer invasion and metastases: A new paradigm for combination therapy in solid cancers
Georg Feldmann et al.
CANCER RESEARCH (2007)
Photodynamic therapy of high grade glioma - long term survival
SS Stylli et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2005)
N-myc downstream-regulated gene 2 (NDRG2) inhibits glioblastoma cell proliferation
YC Deng et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Role of aldehyde dehydrogenases in endogenous and xenobiotic metabolism
V Vasiliou et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2000)
分享论文
